The veterinary medicinal products sector is undergoing an unprecedented regulatory transformation. In this episode, we analyze the adaptation to the new veterinary GMPs (Good Manufacturing Practices) introduced by Regulation (EU) 2019/6 and subsequent directives.We explore the key points from the article by Di Renzo Regulatory Affairs, focusing on:

• The primary differences compared to standards for medicinal products for human use.
• Requirements for manufacturing, importation, and pharmacovigilance.
• Critical deadlines and the importance of a risk-based approach.

Essential listening for Quality Managers, industry professionals, and companies operating within the animal health market.